News

This randomized double blind, placebo controlled study aims to evaluate the safety and immunogenicity of the vaccine candidate in patients with end-stage kidney disease on hemodialysis. This trial

Toviaz (fesoterodine) is available as a 4mg and 8mg prolonged-release tablet. In trials, initial treatment effect was seen as early as two weeks after the start of therapy

The study, which has been designed in consultation with the FDA, is planned for quarters three to four of 2008 and will be the key element in the

As part of Shape, UCB intends to reduce its workforce by 2000 positions throughout the world, representing approximately 17% of its world-wide workforce. The company plans to achieve

Ron Howell, CEO and president of HST Global, said: “Through the use of the EBITDA Capital resources we at HST Global can focus on the issue of bringing

Most recently, Dr Solomon served as COO of Vital Sensors. Dr Solomon studied medicine and received his doctorate at Cornell University Medical College and the Sloan-Kettering division of

As a result of these actions Replidyne will suspend further development activities of REP3123, its investigational agent for the treatment of Clostridium difficile bacteria and C difficile infection,

The main focus of the program is to show how technology can assist in monitoring patients from their home in modern life with the main emphasis being to

Ms Corkern has been with the company for two years, serving as COO, then interim CEO. She also serves on Talyst’s board of directors. She has more than